Holen Sie sich die Stockscreener-App
39.00
8.06%
-3.39
Schlusskurs vom Vortag:
$42.39
Offen:
$42
24-Stunden-Volumen:
290.63K
Relative Volume:
0.36
Marktkapitalisierung:
$1.75B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-47.20M
KGV:
-24.92
EPS:
-1.5653
Netto-Cashflow:
$-43.65M
1W Leistung:
-3.84%
1M Leistung:
+21.04%
6M Leistung:
+184.90%
1J Leistung:
+232.27%
1-Tages-Spanne:
$38.79
$42.56
1-Wochen-Bereich:
$38.79
$43.98
52-Wochen-Spanne:
$4.8069
$44.89
Mbx Biosciences Inc Stock (MBX) Company Profile
Firmenname
Mbx Biosciences Inc
Sektor
Branche
Telefon
(317) 989-3100
Adresse
11711 N. MERIDIAN STREET, CARMEL
Vergleichen Sie MBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
39.00 | 1.90B | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.95 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.78 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.78 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-04 | Eingeleitet | Goldman | Sell |
| 2025-11-04 | Eingeleitet | TD Cowen | Buy |
| 2025-10-15 | Eingeleitet | Truist | Buy |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-08-05 | Eingeleitet | Mizuho | Outperform |
| 2025-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-10 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Eingeleitet | Guggenheim | Buy |
| 2024-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2024-10-08 | Eingeleitet | Jefferies | Buy |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
Assessing MBX Biosciences (MBX) Valuation After A 261% One Year Total Shareholder Return - Yahoo Finance
MBX Biosciences appoints Laurie Stelzer to board of directors By Investing.com - Investing.com Nigeria
MBX Biosciences, Inc. Announces Board and Committee Changes - marketscreener.com
MBX Biosciences appoints Laurie Stelzer to board of directors - Investing.com
MBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair - TipRanks
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair - GlobeNewswire
Forecast Cut: Should I buy MBX Biosciences Inc stock nowEarnings Overview Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
MBX Biosciences (NASDAQ:MBX) Shares Down 6.8%Here's What Happened - MarketBeat
MBX SEC FilingsMBX Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Teladoc (TDOC) and Pfizer (PFE) - The Globe and Mail
Guggenheim raises MBX Biosciences stock price target on obesity drug potential - Investing.com Nigeria
MBX Biosciences Surges Amid Strategic Partnership Developments - timothysykes.com
Breakout Watch: What makes MBX Biosciences Inc stock attractive to growth fundsEarnings Summary Report & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Stifel reiterates Buy rating on MBX Biosciences stock, citing obesity drug pipeline - Investing.com Canada
Stifel reiterates Buy rating on MBX Biosciences stock, citing obesity drug pipeline By Investing.com - Investing.com Nigeria
MBX Biosciences (NASDAQ:MBX) Trading 7.6% HigherTime to Buy? - MarketBeat
MBX Biosciences Sees Shares Surge amid Strategic Partnerships - timothysykes.com
MBX Biosciences Highlights 2026 Outlook and Pipeline Progress - TipRanks
Portfolio Shifts: Is MBX Biosciences Inc stock influenced by commodity pricesJuly 2025 Earnings & Fast Moving Trade Plans - baoquankhu1.vn
Mbx Biosciences Says Phase 3 Trial Of Canvuparatide To Start In Q3 2026 - TradingView — Track All Markets
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference - Sahm
Drug maker maps out once-monthly obesity shots and hormone disorder trial - Stock Titan
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% - MSN
MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
MBX Biosciences (NASDAQ:MBX) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Will MBX Biosciences Inc. stock benefit from upcoming earnings reports2025 Bull vs Bear & Real-Time Buy Zone Alerts - Улправда
Is MBX Biosciences Inc. stock positioned well for digital economyEarnings Growth Summary & High Yield Equity Trading Tips - Улправда
Will MBX Biosciences Inc. stock recover faster than marketJuly 2025 Sector Moves & Real-Time Market Trend Scan - Улправда
MBX Surge: Is It the Right Time? - timothysykes.com
MBX Biosciences (NASDAQ:MBX) Shares Gap UpTime to Buy? - MarketBeat
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday - Benzinga
Will MBX Biosciences Inc. stock attract ESG investors2026 world cup usa national team third place match star players set piece tactics match prediction tactical review - ulpravda.ru
UBS initiates coverage on MBX Biosciences stock with Buy rating - Investing.com
UBS initiates coverage on MBX Biosciences stock with Buy rating By Investing.com - Investing.com Australia
MBX Biosciences (NASDAQ:MBX) Trading Down 8.4%Here's Why - MarketBeat
Power Grid Corporation of India Limited Forms Bullish Flag Upside AheadGlobal Trade Effects & Free Trading Psychology Coaching - earlytimes.in
Commit To Purchase Mbx Biosciences At $20, Earn 25% Using Options - Nasdaq
MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8%Here's What Happened - MarketBeat
MBX Biosciences initiated with a sell at Goldman Sachs - MSN
MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mbx Biosciences stock hits all-time high of 34.85 USD By Investing.com - Investing.com Nigeria
MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8%Still a Buy? - MarketBeat
Mbx Biosciences stock hits all-time high of 34.85 USD - Investing.com
MBX Biosciences price target raised to $50 from $45 at Stifel - MSN
Take Profit: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - moha.gov.vn
MBX Biosciences, Inc.(NasdaqGS:MBX) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) added to NASDAQ Biotechnology Index - marketscreener.com
Dip Buying: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Intraday Action & Stock Portfolio Risk Control - moha.gov.vn
MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen - MarketBeat
How sustainable is MBX Biosciences Inc. stock dividend payoutPortfolio Profit Report & Safe Entry Point Alerts - Улправда
Stifel maintains MBX Biosciences (MBX) buy recommendation - MSN
Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):